Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
30 mai 2018 18h09 HE
|
Akers Biosciences Inc
THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...